Back to top
Top

["Medication, Administered": "Glycoprotein IIb/IIIa Inhibitors"]

Performance/Reporting Period
2020
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent codes that identify glycoprotein Iib/IIIa inhibitors.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a glycoprotein Iib/IIIa inhibitor.
Inclusion Criteria: Includes only relevant concepts associated with a glycoprotein Iib/IIIa inhibitor. These are RxNorm codes.
Exclusion Criteria: No exclusions.

Constrained to codes in the Medication, Administered: Glycoprotein IIb/IIIa Inhibitors value set (2.16.840.1.113762.1.4.1045.41)

QDM Datatype and Definition (QDM Version 5.4)

"Medication, Administered"

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.

Timing: The Relevant Period addresses:

  • startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion, or administering a pill or IM injection to a patient),
  • stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion, or the administration of a pill or IM injection is completed - for pills and IM injections, the start and stop times are the same)

NOTE – Measure developers should address multiple administrations over a period of time using CQL logic.

QDM Attributes

authorDateTime

The time the data element was entered into the clinical software. Note, some datatypes include both Relevant Time and Author dateTime attributes. The purpose is to accommodate Author dateTime if the actual start and stop times are not available when evaluating for feasibility, and also to allow specification of a time for Negation Rationale.
Last Updated: Jul 08, 2021